Khan Samina
Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 16, 2023
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCOfficer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCUnusualMar 3, 2023 2023
Sold 27,813 shares at $85.13 ($2.4M)
Khan Samina, SVP, Chief Medical Officer
Sold 38.7% of holdings ($6.1M position)44,092 shares leftFirst sale on recordFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedMar 7, 2023 +4 days
Sold 3,961 shares at $83.46 ($331k)
Khan Samina, SVP, Chief Medical Officer
Sold 9% of holdings ($3.7M position)40,131 shares leftFiling
- 3 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 15, 2023 +69 days
Filed to sell 288 shares ($25k)
Khan Samina, Officer
No 10b5-1 planFiling
- 4 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 16, 2023 +1 day
Filed to sell 352 shares ($29k)
Khan Samina, Officer
No 10b5-1 planFiling
- 5 Form 4 sale REATA PHARMACEUTICALS INCNo planMay 16, 2023 same day
Sold 640 shares at $83.15 ($53k)
Khan Samina, SVP, Chief Medical Officer
No 10b5-1 planSold 1.6% of holdings ($3.3M position)39,491 shares leftFollows a Form 144Filing
- 6 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 16, 2023 +92 days
Filed to sell 336 shares ($57k)
Khan Samina, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 7 Form 144 notice REATA PHARMACEUTICALS INCNoticeSep 5, 2023 +20 days
Filed to sell 343 shares ($58k)
Khan Samina, Officer
No 10b5-1 plan0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | Sep 5, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 343 | $58k | Notice | SEC | |
| Aug 16, 2023 | Aug 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 336 | $57k | Notice | SEC | |
| May 16, 2023 | May 17, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Medical Officer | Form 4 sale | 640 | $53k | 1.6% | No plan | SEC |
| May 16, 2023 | May 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 352 | $29k | Notice | SEC | |
| May 15, 2023 | May 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 288 | $25k | Notice | SEC | |
| Mar 7, 2023 | Mar 8, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Medical Officer | Form 4 sale | 3,961 | $331k | 9.0% | Plan not stated | SEC |
| Mar 3, 2023 | Mar 6, 2023 | REATA PHARMACEUTICALS INC | SVP, Chief Medical Officer | Form 4 sale | 27,813 | $2.4M | 38.7% | Unusual | SEC |